Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Pazobrite 200 Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Pazopanib (200mg)

Overview Pazobrite 200 Tablet

Sorafenib 200mg tablets are a targeted therapy, inhibiting protein kinases, indicated for kidney and soft tissue cancers. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined individually by your physician, depending on your condition, and may be adjusted. Strict adherence to your doctor's prescription is crucial; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include elevated blood pressure and diarrhea. Your doctor may recommend regular blood pressure checks. Manage diarrhea with increased fluid intake, or seek medical advice if severe. This medication can lower blood cell counts, increasing infection risk. Report fever, flu-like symptoms, or breathlessness immediately. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, particularly anti-infectives, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.

Primary Ingredients of Pazobrite 200 Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Pazobrite 200 Tablet

Renal cell carcinoma/soft tissue sarcoma

Major Benefits of Pazobrite 200 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Pazobrite 200 Tablet on an empty stomach.

Common Side effects of Pazobrite 200 Tablet:

  • Headache
  • Nausea
  • Vomiting
  • Musculoskeletal (bone, muscle or joint) pain
  • Fatigue
  • Change in color of hair
  • Diarrhea
  • High blood pressure
  • Decreased appetite
  • Weight loss
  • Taste change
  • Abnormal skin pigmentation
  • Hair discoloration
  • Tumor pain
  • Breathlessness

How to use Pazobrite 200 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Pazobrite 200 Tablet on an empty stomach.

How Pazobrite 200 Tablet works:

Pazobrite 200 Tablets function as an anti-neoplastic agent. Its mechanism involves targeting and blocking tyrosine kinase enzyme receptors, crucial for cancer cell multiplication. Concurrently, it limits the development of tumor vasculature, thereby hindering cancer progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Pazobrite 200 Tablet is of uncertain safety. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Pazobrite 200 Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Pazobrite 200 Tablets are incompatible; the medication poses a potential risk of infant toxicity.

DrivingDrivingUNSAFE

Taking Pazobrite 200 Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Pazobrite 200 Tablets without requiring any dosage modification.

LiverLiverCAUTION

Patients with liver impairment should use Pazobrite 200 Tablets cautiously, potentially requiring dosage modification under medical supervision. Pazobrite 200 Tablets are contraindicated in individuals with moderate to severe hepatic dysfunction.

What if you forget to take Pazobrite 200 Tablet :

NA

Facts to Know About Pazobrite 200 Tablet

LabelValue
Chemical Type Diarylalkylamines
Developing Habits No.
Treatment Category Cancer Medications
Behavior Class Kinase inhibitors targeting tyrosine

FAQs on Pazobrite 200 Tablet

Pazobrite 200 Tablets are not a standard chemotherapy drug; they're a protein kinase inhibitor. This medication functions by blocking proteins crucial to cancer cell growth and spread.
Take one Pazobrite 200 tablet orally once daily, or as your doctor instructs. Swallow the tablet whole with water; do not crush or break it, as this alters absorption and may increase side effects.
Take Pazobrite 200 Tablets on an empty stomach, at least one hour before or two hours after eating. Food may reduce its effectiveness, potentially requiring a higher dose and increasing the risk of side effects.
Treatment duration with Pazobrite 200 Tablet is individualized. Your doctor will determine the appropriate treatment length based on your response and tolerability. Always consult your doctor before discontinuing this medication.
Grapefruit and grapefruit juice should be avoided while taking Pazobrite 200 Tablets, as they can interfere with the medication's effectiveness. Consult your doctor regarding other potential dietary restrictions.
Treatment duration with Pazobrite 200 Tablet is individualized. Your doctor will determine the appropriate treatment length based on your response and tolerance. Never discontinue use without consulting your physician. Continue taking it as directed for as long as it remains beneficial and well-tolerated.
Pazobrite 200 Tablets can severely damage the liver, potentially fatally. Report any history of liver disease to your doctor. Immediately contact your doctor if you experience symptoms like jaundice (yellow skin or eyes), dark urine, fatigue, nausea, vomiting, appetite loss, upper right abdominal pain, or unusual bleeding/bruising. Your doctor may order blood tests before, and at weeks 3, 5, 7, and 9, then months 3 and 4, after starting Pazobrite 200 Tablets. Further testing may be necessary; regular monitoring will continue after 4 months.
Pazobrite 200 Tablet
4,502
MRP 5,211
13% off